145 related articles for article (PubMed ID: 9619351)
1. Complexities, pitfalls, and strategies for evaluating brain tumor therapies.
Kaplan RS
Curr Opin Oncol; 1998 May; 10(3):175-8. PubMed ID: 9619351
[No Abstract] [Full Text] [Related]
2. Local control of gliomas: the next best step--a good step?
Westphal M; Giese A
Front Radiat Ther Oncol; 1999; 33():214-26. PubMed ID: 10549491
[No Abstract] [Full Text] [Related]
3. Management-Based Structured Reporting of Posttreatment Glioma Response With the Brain Tumor Reporting and Data System.
Weinberg BD; Gore A; Shu HG; Olson JJ; Duszak R; Voloschin AD; Hoch MJ
J Am Coll Radiol; 2018 May; 15(5):767-771. PubMed ID: 29503151
[No Abstract] [Full Text] [Related]
4. Current knowledge and treatment strategies for grade II gliomas.
Narita Y
Neurol Med Chir (Tokyo); 2013; 53(7):429-37. PubMed ID: 23883553
[TBL] [Abstract][Full Text] [Related]
5. Brain stem gliomas: therapeutic options at time of recurrence.
Rekate HL
Pediatr Neurosurg; 1996 Oct; 25(4):220. PubMed ID: 9293549
[No Abstract] [Full Text] [Related]
6. Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
Krishnatry R; Zhukova N; Guerreiro Stucklin AS; Pole JD; Mistry M; Fried I; Ramaswamy V; Bartels U; Huang A; Laperriere N; Dirks P; Nathan PC; Greenberg M; Malkin D; Hawkins C; Bandopadhayay P; Kieran MW; Manley PE; Bouffet E; Tabori U
Cancer; 2016 Apr; 122(8):1261-9. PubMed ID: 26970559
[TBL] [Abstract][Full Text] [Related]
7. Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Stupp R; Roila F;
Ann Oncol; 2008 May; 19 Suppl 2():ii83-5. PubMed ID: 18456781
[No Abstract] [Full Text] [Related]
8. Grade II gliomas-not so low grade.
Shonka NA
Oncology (Williston Park); 2014 Dec; 28(12):1016. PubMed ID: 25510801
[No Abstract] [Full Text] [Related]
9. Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis.
Kline C; Felton E; Allen IE; Tahir P; Mueller S
J Neurooncol; 2018 Mar; 137(1):103-110. PubMed ID: 29204840
[TBL] [Abstract][Full Text] [Related]
10. Irradiation and bevacizumab in high-grade glioma retreatment settings.
Niyazi M; Ganswindt U; Schwarz SB; Kreth FW; Tonn JC; Geisler J; la Fougère C; Ertl L; Linn J; Siefert A; Belka C
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):67-76. PubMed ID: 21030162
[TBL] [Abstract][Full Text] [Related]
11. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
[TBL] [Abstract][Full Text] [Related]
12. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
Pollack IF; Claassen D; al-Shboul Q; Janosky JE; Deutsch M
J Neurosurg; 1995 Apr; 82(4):536-47. PubMed ID: 7897512
[TBL] [Abstract][Full Text] [Related]
13. The inherent invasiveness of cerebral gliomas: implications for clinical management.
Laws ER; Shaffrey ME
Int J Dev Neurosci; 1999; 17(5-6):413-20. PubMed ID: 10571404
[No Abstract] [Full Text] [Related]
14. Immunotherapy and biological modifiers for the treatment of malignant brain tumors.
Marras C; Mendola C; Legnani FG; DiMeco F
Curr Opin Oncol; 2003 May; 15(3):204-8. PubMed ID: 12778012
[TBL] [Abstract][Full Text] [Related]
15. Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.
Buckner JC; Brown LD; Kugler JW; Cascino TL; Krook JE; Mailliard JA; Kardinal CG; Tschetter LK; O'Fallon JR; Scheithauer BW
J Neurosurg; 1995 Mar; 82(3):430-5. PubMed ID: 7861221
[TBL] [Abstract][Full Text] [Related]
16. Interstitial brachytherapy versus cytoreductive surgery in recurrent malignant glioma.
Ryken TC; Hitchon PW; VanGilder JC; Wen BC; Jani S
Stereotact Funct Neurosurg; 1994; 63(1-4):241-5. PubMed ID: 7624640
[TBL] [Abstract][Full Text] [Related]
17. Head's up on the treatment of malignant glioma patients.
Armstrong TS
Oncol Nurs Forum; 2009 Sep; 36(5):E232-40. PubMed ID: 19726382
[No Abstract] [Full Text] [Related]
18. A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia.
Fiorentini G; Giovanis P; Rossi S; Dentico P; Paola R; Turrisi G; Bernardeschi P
In Vivo; 2006; 20(6A):721-4. PubMed ID: 17203754
[TBL] [Abstract][Full Text] [Related]
19. Early initiation of chemoradiation may not influence survival of high-grade gliomas.
Loureiro LVM; Malheiros SMF
J Neurooncol; 2018 Jan; 136(1):215-216. PubMed ID: 29116482
[No Abstract] [Full Text] [Related]
20. Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas.
Wick W; Winkler F
Cancer; 2018 Jul; 124(13):2674-2676. PubMed ID: 29698549
[No Abstract] [Full Text] [Related]
[Next] [New Search]
